复锐医疗科技有限公司（股票代码：01696）于2026年10月15日发布公告称，公司依据2026年6月24日股东大会授予的股份回购一般授权，于香港联交所回购普通股合计10万股，占该回购前已发行股本约0.021%。回购价格介乎每股1.785港元至1.86港元，合计支付约18.10万港元。
本次回购完成后，公司已发行股本（不包括库藏股）由原先的468,144,692股降至468,044,692股，持作库藏股的股份增至298,400股，公司已发行股份总数维持在468,343,092股。公司表示，截至目前，依据前述回购授权已累计回购298,400股股份，占该授权项下允许回购股份总数（46,834,309股）的约0.064%。
公告称，公司确认该等股份回购均符合香港联交所证券上市规则和相关法律法规的规定，并已履行有关法定义务。公告由公司秘书方前厉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.